Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01336101
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01336101 -
U1111-1121-6816
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01336101. Allocation not applicable; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2012-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
- Acronym
- SUMMIT
- Condition
- Peripheral Arterial Diseases
- Condition
- Superficial Femoral Artery Stenosis
- Intervention (Device)
- EPIC™ Self-Expanding Nitinol Vascular Stent
- Lead sponsor
- Provascular GmbH
- Collaborator
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01336101- Content hash
ea031f1d2e0561060ce1a9f63a345d81222fa70d986e6ee0b99a830b5964da43